01/11/2014 03:41:38 Free Membership Login

Exactech News (NASDAQ:EXAC)

DateTimeSource
Headline
10/21/20144:00PMBWExactech Q3 Revenue Up 4% to $57.9 Million; Net Income Down 6% to $3.0 Million Due to Currency Losses; Q3 Diluted EPS $0.21 v...
Nine Months Revenue Up 5% to $185.1 Million; Net Income Up 5% to $11.4 Million or $0.81 EPDS Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today revenue of $57.9 million for the third quarter of 2014, a 4% increase over $55.7... More...>>
10/13/20144:50PMBWExactech Schedules Q3 2014 Earnings Release and Conference Call
Company Expects Q3 Revenue to be at Lower Range of Guidance and Earnings to Fall Below Guidance Due to Currency Impact Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its third quarter 2014 financial results... More...>>
10/09/201411:45AMBWExactech Innovations Presented at Recent Key Scientific Conferences
ICJR Transatlantic Congress Featured Pasquale Petrera, MD, on ExactechGPS® Guided Personalized Surgery Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, recounted today the significant number of scientific posters and presentations... More...>>
08/13/20148:17AMBWExactech Announces First Implantation of New Alteon™ Tapered Wedge Femoral Stem
New Hip Replacement Design Targets Improvements for Hip Patients Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, is proud to announce the first implantation of the Alteon™ Tapered Wedge Femoral Stem. The surgery took... More...>>
07/28/20144:05PMBWExactech Q2 Revenue Up 6% to $63.9 Million. Net Income up 12% to $4.2 Million. Diluted EPS $0.30 vs. $0.27.
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today revenue of $63.9 million for the second quarter of 2014, a 6% increase over $60.6 million in the second quarter of 2013. Net income was $4.2 million, or $0.30 per diluted share... More...>>
07/10/20149:55AMBWExactech Schedules Second Quarter 2014 Earnings Release and Conference Call
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its second quarter 2014 financial results on Monday, July 28th, 2014. A copy of the earnings release will be available at http://www.hawkassociates.com. The... More...>>
07/03/20148:17AMBWExactech Launches New Porous Technology for Total Knee Arthroplasty
Supporting Study to be Presented at European Orthopaedic Research Society Annual Meeting Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today the international launch of Optetrak Logic® Porous, a new porous... More...>>
06/11/20148:20AMBWTwenty ExactechGPS® Guided Personalized Surgery Abstracts Accepted into Five Leading Orthopaedic Conferences
Twenty Exactech Knee abstracts, featuring the company’s breakthrough technology ExactechGPS® Guided Personalized Surgery, have been accepted into five leading orthopaedic conferences: The European Federation of National Associations of Orthopaedics and Traumatology (EFORT) annual congress (June 4-6) The South Korean... More...>>
06/04/20148:24AMBWExactech Announces First International Introduction of ExactechGPS® Guided Personalized Surgery at 15th EFORT Congress
Live Demonstrations to Feature Practical Experience with Exactech’s Latest Innovations Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today its slate of products to be featured at the company’s technical... More...>>
05/15/20148:21AMBWW. Andrew Krusen Elected to Exactech Board of Directors
Dr. Bill Petty and Richard Smith Re-elected to Three Year Terms Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that W. Andrew Krusen was elected to the Board of Directors at the company’s annual meeting... More...>>
04/21/20144:00PMBWExactech Q1 Revenue Up 7% to $63.3 Million; Net Income up 9% to $4.2 Million; Diluted EPS $0.30 vs. $0.29
Strong Double Digit Extremities Revenue Growth Continues Above Expectations Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today revenue of $63.3 million for the first quarter of 2014, a 7% increase over $59.3... More...>>
04/11/20146:35PMPRNUSFaruqi & Faruqi, LLP Launches An Investigation Against Exactech Inc. (EXAC) Potential Breaches Of Fiduciary Duties By Its Boa...
Faruqi & Faruqi, LLP Launches An Investigation Against Exactech Inc. (EXAC) Potential Breaches Of Fiduciary Duties By Its Board Of Directors Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Exactech Inc. PR Newswire NEW YORK, April... More...>>
04/09/20142:30PMBWExactech Schedules First Quarter 2014 Earnings Release and Conference Call
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its first quarter 2014 financial results on Monday, April 21st, 2014. A copy of the earnings release will be available at http://www.hawkassociates.com. The... More...>>
04/03/20148:07AMBWExactech To Conduct Intercontinental Masters Course in Shoulder Arthroplasty
Company Leverages Technology to Address Global Demand for Medical Education for Industry’s Fastest Growing Shoulder Replacement System Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that it will conduct... More...>>
03/26/20143:30PMBWExactech Promotes President David Petty To Chief Executive Officer; Dr. Bill Petty Named Executive Chairman
Exactech, Inc. (Nasdaq: EXAC) is a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials. The company announced today that President David Petty has been promoted to Chief Executive Officer effective immediately. Dr. Bill Petty, co-founder and CEO of the company... More...>>
03/24/201410:00AMBWExactech Knee, Hip and Shoulder Innovations Presented at the 2014 Orthopaedic Research Society Annual Meeting
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, presented scientific posters and presentations regarding its latest advancements for shoulder and knee replacement surgery during the 2014 Orthopaedic Research Society annual... More...>>
03/11/20149:32AMBWExactechGPS: Guided Personalized Surgery Takes Main Stage Among Exactech’s Orthopaedic Innovations at AAOS 2014 Annual Meet...
Newly Designed Educational Exhibit Provides Live Demos, Hands on Experience and “Ask the Expert” Exchange Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today its line up of products to be unveiled at the... More...>>
03/07/201410:30AMBWExactech Broadens Equinoxe® Shoulder System Development With Introduction Of Resurfacing Humeral Head
Fastest Growing Shoulder System Continues to Drive Exactech’s Growth Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today successful first surgeries using the company’s new Equinoxe® Resurfacing Humeral... More...>>
03/05/201410:00AMBWExactech Celebrates 20 Years of Exactech Knee with Launch of New Real-Time Patient-Specific Solution in TKA
Company to showcase new advanced surgical technology at AAOS 2014 Annual Meeting Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products, commemorates the twentieth anniversary of its knee system with the launch of ExactechGPS® Guided Personalized Surgery, the first advanced surgical... More...>>
02/19/20144:00PMBWExactech 2013 Revenue Up 6% to $237.1M, Net Income Up 21% to $15.4M, EPS $1.12
4Q’13 Revenue Up 4% to $61.6M, Net Income Up 18% to $4.6M, EPS $0.33 Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today that revenue for 2013 increased 6% to $237.1 million from $224.3 million in 2012. Diluted earnings per... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq exac141101 03:41